Search results
Fulcrum Therapeutics stock target lifted, maintains buy on Sanofi deal By Investing.com
Investing.com· 3 days agoOn Monday, Stifel, a financial services firm, raised its price target on shares of Fulcrum...
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Investor's Business Daily· 6 days agoNovavax shares shot more than 125% higher Friday on news of a Covid-19 vaccine licensing agreement...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters via Yahoo News· 7 days ago(Reuters) -Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with ...
After FTC stalled Sanofi deal, Shionogi secures Maze's Pompe disease drug for $150M
FierceBiotech· 7 days agoIt appears Sanofi’s loss is Shionogi’s gain. Five months after the Federal Trade Commission (FTC) scuttled Sanofi’s attempt to acquire Maze Therapeutics ...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 4 days ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 3 days agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 7 days agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
Barrons.com· 6 days agoNovavax the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 6 days agoThe French drug giant Sanofi is taking a minority stake in Novavax and entering into a licensing...
Sanofi gambles $80M on Fulcrum’s muscular dystrophy drug
BioPharma Dive via Yahoo Finance· 4 days agoThe deal gives the pharma partial rights to a medicine GSK once developed for heart disease but...